Literature DB >> 20807032

Respiratory tract allergic disease and atopy: experimental evidence for a fungal infectious etiology.

Paul Porter1, Sumanth Polikepahad, Yuping Qian, J Morgan Knight, Wen Lu, Wendy M-T Tai, Luz Roberts, Valentine Ongeri, Tianshu Yang, Alexander Seryshev, Stuart Abramson, George L Delclos, Farrah Kheradmand, David B Corry.   

Abstract

Allergic asthma is an obstructive lung disease linked to environmental exposures that elicit allergic airway inflammation and characteristic antigen-specific immunoglobulin reactions termed atopy. Analyses of asthma pathogenesis using experimental models have shown that T helper cells, especially T helper type 2 (Th2) cells and Th2 cytokines such as interleukin 4 (IL-4) and IL-13, are critical mediators of airway obstruction following allergen challenge, but the environmental initiators of lung Th2 responses are less defined. Our studies demonstrate that fungal-derived proteinases that are commonly found in home environments are requisite immune adjuvants capable of eliciting robust Th2 responses and allergic lung disease in mice. We have further shown that common household fungi readily infect the mouse respiratory tract and induce both asthma-like disease and atopy to otherwise innocuous bystander antigens through the secretion of proteinases. These findings support the possibility that asthma and atopy represent a reaction to respiratory tract fungal infection, suggesting novel means for diagnosis and therapy of diverse allergic disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807032      PMCID: PMC4079113          DOI: 10.3109/13693786.2010.509743

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  51 in total

1.  The proteolytic activity of Der p 1 selectively enhances IgE synthesis: a link between allergenicity and cysteine protease activity.

Authors:  F Shakib; L Gough
Journal:  Clin Exp Allergy       Date:  2000-06       Impact factor: 5.018

2.  IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment.

Authors:  C I Ezeamuzie; S Al-Ali; M Khan; Z Hijazi; A Dowaisan; M S Thomson; J Georgi
Journal:  Int Arch Allergy Immunol       Date:  2000-04       Impact factor: 2.749

3.  A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.

Authors:  D A Stevens; H J Schwartz; J Y Lee; B L Moskovitz; D C Jerome; A Catanzaro; D M Bamberger; A J Weinmann; C U Tuazon; M A Judson; T A Platts-Mills; A C DeGraff
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

4.  Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi.

Authors:  P Porter; S C Susarla; S Polikepahad; Y Qian; J Hampton; A Kiss; S Vaidya; S Sur; V Ongeri; T Yang; G L Delclos; S Abramson; F Kheradmand; D B Corry
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

5.  Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient: case report.

Authors:  Melissa Orzechowski Xavier; Maria da Penha Uchoa Sales; José de Jesus Peixoto Camargo; Alessandro Comarú Pasqualotto; Luiz Carlos Severo
Journal:  Rev Soc Bras Med Trop       Date:  2008 Mar-Apr       Impact factor: 1.581

6.  Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study.

Authors:  David W Denning; B Ronan O'Driscoll; Georgina Powell; Fiona Chew; Graham T Atherton; Aashish Vyas; John Miles; Julie Morris; Robert M Niven
Journal:  Am J Respir Crit Care Med       Date:  2008-10-23       Impact factor: 21.405

7.  A new mechanism regulating the initiation of allergic airway inflammation.

Authors:  Attila Kiss; Martin Montes; Sarat Susarla; Elin A Jaensson; Scott M Drouin; Rick A Wetsel; Zhengbin Yao; Rachel Martin; Nabeel Hamzeh; Rebecca Adelagun; Sheila Amar; Farrah Kheradmand; David B Corry
Journal:  J Allergy Clin Immunol       Date:  2007-06-04       Impact factor: 10.793

8.  The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response.

Authors:  L Gough; O Schulz; H F Sewell; F Shakib
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

9.  Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein.

Authors:  Aurelien Trompette; Senad Divanovic; Alberto Visintin; Carine Blanchard; Rashmi S Hegde; Rajat Madan; Peter S Thorne; Marsha Wills-Karp; Theresa L Gioannini; Jerry P Weiss; Christopher L Karp
Journal:  Nature       Date:  2008-12-07       Impact factor: 49.962

10.  Interleukin 25 promotes the initiation of proallergic type 2 responses.

Authors:  Pornpimon Angkasekwinai; Heon Park; Yui-Hsi Wang; Yi-Hong Wang; Seon Hee Chang; David B Corry; Yong-Jun Liu; Zhou Zhu; Chen Dong
Journal:  J Exp Med       Date:  2007-06-11       Impact factor: 14.307

View more
  11 in total

1.  High prevalence of asthma in HIV-infected adults: new insights.

Authors:  William T Shearer; David B Corry
Journal:  J Allergy Clin Immunol       Date:  2012-01-31       Impact factor: 10.793

Review 2.  Eosinophilia in patients infected with human immunodeficiency virus.

Authors:  Andrew Chou; Jose A Serpa
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

3.  Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease.

Authors:  Paul C Porter; Luz Roberts; Anna Fields; Morgan Knight; Yuping Qian; George L Delclos; Shuhua Han; Farrah Kheradmand; David B Corry
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

4.  Higher Environmental Relative Moldiness Index (ERMI) values measured in homes of asthmatic children in Boston, Kansas City, and San Diego.

Authors:  Stephen Vesper; Charles Barnes; Christina E Ciaccio; Alan Johanns; Kevin Kennedy; Johnna S Murphy; Arcela Nunez-Alvarez; Megan T Sandel; David Cox; Gary Dewalt; Peter J Ashley
Journal:  J Asthma       Date:  2012-11-09       Impact factor: 2.515

5.  Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.

Authors:  Shyny Koshy; Redwan Huq; Mark R Tanner; Mustafa A Atik; Paul C Porter; Fatima S Khan; Michael W Pennington; Nicola A Hanania; David B Corry; Christine Beeton
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

6.  Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization.

Authors:  Yifan Wu; Zhimin Zeng; Yubiao Guo; Lizhen Song; Jill E Weatherhead; Xinyan Huang; Yuying Zeng; Lynn Bimler; Cheng-Yen Chang; John M Knight; Christian Valladolid; Hua Sun; Miguel A Cruz; Bernhard Hube; Julian R Naglik; Amber U Luong; Farrah Kheradmand; David B Corry
Journal:  Immunity       Date:  2021-09-09       Impact factor: 31.745

Review 7.  Fungi in Bronchiectasis: A Concise Review.

Authors:  Luis Máiz; Rosa Nieto; Rafael Cantón; Elia Gómez G de la Pedrosa; Miguel Ángel Martinez-García
Journal:  Int J Mol Sci       Date:  2018-01-04       Impact factor: 5.923

8.  Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis.

Authors:  Evan Li; Chu-Lin Tsai; Zahida K Maskatia; Ekta Kakkar; Paul Porter; Roger D Rossen; Sarah Perusich; John M Knight; Farrah Kheradmand; David B Corry
Journal:  Immun Inflamm Dis       Date:  2018-03-25

9.  Transient Ascaris suum larval migration induces intractable chronic pulmonary disease and anemia in mice.

Authors:  Yifan Wu; Evan Li; Morgan Knight; Grace Adeniyi-Ipadeola; Li-Zhen Song; Alan R Burns; Ana Clara Gazzinelli-Guimaraes; Ricardo Fujiwara; Maria Elena Bottazzi; Jill E Weatherhead
Journal:  PLoS Negl Trop Dis       Date:  2021-12-16

10.  The impact of Aspergillus fumigatus viability and sensitization to its allergens on the murine allergic asthma phenotype.

Authors:  Sumali Pandey; Scott A Hoselton; Jane M Schuh
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.